Inhibition of RAS function through targeting an allosteric regulatory site
Russell Spencer-Smith(MUSC Hollings Cancer Center), John P. O’Bryan(Illinois College), Hugo Lavoie(Institute for Research in Immunology and Cancer), Mustafa Nazir Okur(University of Illinois Chicago), Mitsuhiko Ikura(Princess Margaret Cancer Centre), Shohei Koide(NYU Langone Health), Ankit Gupta(University of Chicago), Raphael R. Eguchi(Stanford University), John F. Hancock(The University of Texas MD Anderson Cancer Center), Miranda L. Jacobs(University of Illinois Chicago), Thanashan Rajakulendran(University of Toronto), Marc Therrien(Institute for Research in Immunology and Cancer), Evan Dowdell(University of Chicago), Frank Sicheri(University of Toronto), Fern Sha(University of Chicago), Akiko Koide(University of Chicago), Erika Herrero-Garcia(Jesse Brown VA Medical Center), Matthew J. Smith(University of Toronto), Jacqueline Cobbert(University of Illinois Chicago), Priyanka Gajwani(University of Illinois Chicago), Dianicha Santana(University of Illinois Chicago), Irina Dementieva(University of Chicago), Yong Zhou(Jiangsu University)
Cited by 299
Related Papers
ERK signalling: a master regulator of cell behaviour, life and fate
|Nature Reviews Molecular Cell Biology|2020|1.2k
Crystal structure of the Src family tyrosine kinase Hck
|Nature|1997|1.2k
Regulation of RAF protein kinases in ERK signalling
|Nature Reviews Molecular Cell Biology|2015|701